Literature DB >> 19897550

Prevalence of sarcoidosis in Switzerland is associated with environmental factors.

U Deubelbeiss1, A Gemperli, C Schindler, F Baty, M H Brutsche.   

Abstract

The current study aimed to investigate incidence, prevalence and regional distribution of sarcoidosis in Switzerland with respect to environmental exposures. All sarcoidosis patients hospitalised between 2002 and 2005 were identified from the Swiss hospital statistics from the Swiss Federal Office for Statistics (Neuchâtel, Switzerland). Regional exposure characteristics included the regional distribution of different industrial sectors, agriculture and air quality. Co-inertia analysis, as well as a generalised linear model, was applied. The prevalence of "ever-in-life" diagnosed sarcoidosis, currently active sarcoidosis and sarcoidosis requiring hospitalisation was 121 (95% CI 93-149), 44 (95% CI 34-54) and 16 (95% CI 10-22) per 100,000 inhabitants, respectively. The mean annual incidence of sarcoidosis was 7 (95% CI 5-11) per 100,000 inhabitants. The regional workforce in the metal industry, water supply, air transport factories and the area of potato production, artificial meadows (grassland) and bread grains were positively associated with the frequency of sarcoidosis. The prevalence of sarcoidosis was higher than assumed based on former international estimates. Higher frequency was found in regions with metal industry and intense agriculture, especially production of potatoes, bread grains and artificial meadows.

Entities:  

Mesh:

Year:  2009        PMID: 19897550     DOI: 10.1183/09031936.00197808

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

Review 1.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

Review 2.  Climate Change and Inpatient Dermatology.

Authors:  R Fathy; Misha Rosenbach
Journal:  Curr Dermatol Rep       Date:  2020-08-22

Review 3.  Interleukin-12 family cytokines and sarcoidosis.

Authors:  Sabine Ringkowski; Paul S Thomas; Cristan Herbert
Journal:  Front Pharmacol       Date:  2014-10-27       Impact factor: 5.810

Review 4.  Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?

Authors:  Irving E Perez; Mario J Garcia; Cynthia C Taub
Journal:  Curr Cardiol Rev       Date:  2016

5.  In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012.

Authors:  Susanne Pohle; Florent Baty; Martin Brutsche
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Sarcoidosis in an Italian province. Prevalence and environmental risk factors.

Authors:  Deborah Beghè; Luca Dall'Asta; Claudia Garavelli; Augusto Alberto Pastorelli; Marilena Muscarella; Gloria Saccani; Marina Aiello; Ernesto Crisafulli; Massimo Corradi; Paolo Stacchini; Alfredo Chetta; Giuseppina Bertorelli
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

7.  Occupational exposure as a presumable cause of subcutaneous sarcoidosis in a tannery worker - case report and review of the literature.

Authors:  Małgorzata M Michalska-Jakubus; Katarzyna Zdeb; Beata Rymgayłło-Jankowska; Agnieszka Korolczuk; Tomasz Żarnowski; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

8.  Sarcoidosis and silica dust exposure among men in Sweden: a case-control study.

Authors:  Pål Graff; Johanna Larsson; Ing-Liss Bryngelsson; Pernilla Wiebert; Per Vihlborg
Journal:  BMJ Open       Date:  2020-09-03       Impact factor: 2.692

9.  Study of environmental health problems in Korea using integrated environmental health indicators.

Authors:  Seulkee Heo; Jong-Tae Lee
Journal:  Int J Environ Res Public Health       Date:  2013-07-25       Impact factor: 3.390

Review 10.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.